77 related articles for article (PubMed ID: 28351579)
21. External validation of a multi-institutional retroperitoneal sarcoma nomogram.
Raut CP; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Fiore M; Callegaro D; Casali PG; Haas RL; Hayes AJ; Honore C; Cannell AJ; Jakob J; Szacht M; Fairweather M; Pollock RE; Bonvalot S; Gronchi A
Cancer; 2016 May; 122(9):1417-24. PubMed ID: 26916507
[TBL] [Abstract][Full Text] [Related]
22. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
23. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma.
Li J; Zhou J; Yang PH; Xia Y; Shi YH; Wu D; Lv G; Zheng W; Wang K; Wan XY; Lau WY; Wu MC; Fan J; Shen F
Eur J Cancer; 2016 Jul; 62():86-95. PubMed ID: 27232330
[TBL] [Abstract][Full Text] [Related]
24. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Huang PY; Cao KJ; Guo X; Mo HY; Guo L; Xiang YQ; Deng MQ; Qiu F; Cao SM; Guo Y; Zhang L; Li NW; Sun R; Chen QY; Luo DH; Hua YJ; Mai HQ; Hong MH
Oral Oncol; 2012 Oct; 48(10):1038-1044. PubMed ID: 22591726
[TBL] [Abstract][Full Text] [Related]
26. Nomograms containing body dose parameters for predicting survival in patients with nasopharyngeal carcinoma.
Jiang J; Zhai R; Kong F; Du C; Ying H
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):181-192. PubMed ID: 37552282
[TBL] [Abstract][Full Text] [Related]
27. A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II-IVa Nasopharyngeal Carcinoma.
Yang K; Zhang Q; Zhang M; Xie W; Li M; Zeng L; Wang Q; Zhao J; Li Y; Li G
Front Oncol; 2021; 11():640077. PubMed ID: 34552862
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
[TBL] [Abstract][Full Text] [Related]
29. Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients.
Cho JK; Lee GJ; Yi KI; Cho KS; Choi N; Kim JS; Kim H; Oh D; Choi SK; Jung SH; Jeong HS; Ahn YC
Eur J Cancer; 2015 Jul; 51(10):1303-11. PubMed ID: 25934438
[TBL] [Abstract][Full Text] [Related]
30. Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.
Yoon WS; Yang DS; Lee JA; Lee NK; Park YJ; Kim CY; Lee NW; Hong JH; Lee JK; Song JY
Biomed Res Int; 2017; 2017():2917925. PubMed ID: 28536694
[No Abstract] [Full Text] [Related]
31. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
[TBL] [Abstract][Full Text] [Related]
32. Nomograms incorporating primary tumor response at mid-radiotherapy to predict survival in locoregionally advanced nasopharyngeal carcinoma.
Liu X; Huang J; Qin Y; Zhang Z; Wu B; Yang K
Head Neck; 2023 Aug; 45(8):1922-1933. PubMed ID: 37204765
[TBL] [Abstract][Full Text] [Related]
33. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
[TBL] [Abstract][Full Text] [Related]
34. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
35. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.
Franchin G; Vaccher E; Talamini R; Politi D; Gobitti C; Minatel E; Lleshi A; Sartor G; Mascarin M; Rumeileh IA; Trovò MG; Barzan L
Oral Oncol; 2011 Sep; 47(9):905-9. PubMed ID: 21783403
[TBL] [Abstract][Full Text] [Related]
37. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
[TBL] [Abstract][Full Text] [Related]
38. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
40. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L;
Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
